Literature DB >> 9861840

Persistent oral candidosis by non-albicans Candida strains including Candida glabrata in a human immunodeficiency virus-infected patient observed over a period of 6 years.

L Hoegl1, E Thoma-Greber, M Röcken, H C Korting.   

Abstract

A 38-year-old woman infected with human immunodeficiency virus (HIV) presented with persistent oral candidosis in which non-albicans Candida strains were the predominant yeasts in most of the examinations performed over a period of 6 years. Oral treatment with fluconazole had no effect on clinical signs of oral candidosis. In 8 of a total of 11 specimens, Candida glabrata, Candida parapsilosis and Candida tropicalis were at least suspected as the causative pathogens of oral candidosis. The non-response to fluconazole in our patient could be explained by in vitro resistance to fluconazole of detected Candida glabrata and Candida tropicalis isolates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9861840     DOI: 10.1111/j.1439-0507.1998.tb00347.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  3 in total

1.  Susceptibility pattern and molecular type of species-specific Candida in oropharyngeal lesions of Indian human immunodeficiency virus-positive patients.

Authors:  Ali Abdul Lattif; Uma Banerjee; Rajendra Prasad; Ashutosh Biswas; Naveet Wig; Neeraj Sharma; Absarul Haque; Nivedita Gupta; Najma Z Baquer; Gauranga Mukhopadhyay
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

2.  Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation.

Authors:  Spencer W Redding; William R Kirkpatrick; Stephen Saville; Brent J Coco; William White; Annette Fothergill; Michael Rinaldi; Tony Eng; Thomas F Patterson; Jose Lopez-Ribot
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

3.  Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013.

Authors:  Yoshiaki Kamikawa; Youichirou Mori; Tomohiro Nagayama; Junichi Fujisaki; Daisuke Hirabayashi; Ryoichi Sakamoto; Tomofumi Hamada; Kazumasa Sugihara
Journal:  BMC Oral Health       Date:  2014-02-20       Impact factor: 2.757

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.